Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies

BACKGROUND: A majority of patients with pancreatic malignancies, including both pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumours (pNETs), present with advanced disease due to a lack of specific symptoms and current diagnostic limitations, making this disease extremely di...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, R, Zurakowski, D, Wischhusen, J, Frauenhoffer, C, Hooshmand, S, Kulke, M, Moses, M A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453724/
https://www.ncbi.nlm.nih.gov/pubmed/25137018
http://dx.doi.org/10.1038/bjc.2014.462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453724/
https://www.ncbi.nlm.nih.gov/pubmed/25137018
http://dx.doi.org/10.1038/bjc.2014.462

Ejemplares similares